Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia - Concepedia

Concepedia

Publication | Open Access

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

DOI Full Paper Access

104

Citations

38

References

2017

Year

H. Jean Khoury, Robert H. Collins, William Blum, Patrick S. Stiff, Laurence Elias, Jane Lebkowski, Anita Reddy, Kevin Nishimoto, Debasish Sen, Edward D. Wirth,

Abstract

The generation of hTERT-DCs is feasible and vaccination with hTERT-DCs appears to be safe and may be associated with favorable recurrence-free survival. Cancer 2017;123:3061-72. © 2017 American Cancer Society.

References

	Year	Citations

Page 1